Market Overview:
The global embolic protection devices market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of cardiovascular diseases, neurovascular diseases, and peripheral diseases. In addition, the growing demand for minimally invasive procedures is also contributing to the growth of this market. The global embolic protection devices market can be segmented by type, application, and region. By type, the market can be divided into distal filter devices, distal occlusion devices, and proximal occlusion devices. By application, the market can be classified into cardiovascular diseases (such as myocardial infarction and stroke), neurovascular diseases (such as aneurysm and AVM), and peripheral vascular diseases (such as atherosclerosis). The global embolic protection devices market is dominated by North America followed by Europe.
Product Definition:
Embolic protection devices are used to protect the patient from embolic material that may dislodge during a medical procedure. The devices work by trapping the embolic material and preventing it from traveling to other parts of the body. The importance of embolic protection devices is that they can help prevent serious complications, such as stroke, caused by emboli.
Distal Filter Devices:
Distal filter devices, also known as distal protection devices or DP device is a medical device used to clear blood from the extremities. It works by creating a vacuum that draws the blood towards it and then removes it via suction. The process is usually painless and can be done at any time without causing any harm to the patient.
The global distal filter devices market size was valued at USD 661 million in 2016.
Distal Occlusion Devices:
Distal occlusion devices refer to the portion of a catheter that is furthest from the patient's body. It is used in various medical procedures such as angioplasty, cardiac electrophysiology testing, and peripheral vascular interventions. The distal end of a catheter typically refers to the tip or needle that is inserted into the blood vessel.
Application Insights:
Based on application, the market is segmented into cardiovascular diseases, neurovascular diseases, peripheral diseases and others. The cardiovascular disease segment dominated the global embolic protection devices market in 2017 owing to a high prevalence of patients suffering from heart-related disorders such as stroke and heart attack. According to data published by WHO in 2018, out of 17 million deaths globally every year due to Cardiovascular Diseases (CVDs), around 60% occur in low- and middle-income countries. Thus, increasing incidence rates coupled with a growing aging population are expected to drive demand for embolic protection devices over the forecast period.
The neurovascular disease segment is anticipated to witness lucrative growth during the forecast period owing to an increase in number of patients suffering from conditions such as brain aneurysm or cerebral arteriovenous malformations that require treatment with endovascular procedures for removal or sealing off blood vessels without causing any damage either inside or outside of brain tissue.
Regional Analysis:
North America held the largest revenue share in 2017. The region is expected to maintain its dominance throughout the forecast period owing to high healthcare expenditure, technological advancements, and increasing prevalence of target diseases such as stroke, TIA/mini-stroke, brain tumor, & aneurysm. In addition rising geriatric population prone to cardiovascular diseases (CVDs) is also one of the major factors contributing toward regional growth.
Asia Pacific is anticipated to be the fastest growing region over a period of eight years due to various factors such as economic development and improvement in healthcare infrastructure leading towards better diagnosis and treatment options for patients suffering from Embolic Protection Devices (EPDs). Moreover Asia Pacific has one of the highest birth rates in world which increases susceptibility towards CVDs thus driving demand for EPD devices among surgeons & physicians treating these conditions.
Growth Factors:
- Increasing incidence of cardiovascular diseases (CVDs) due to changing lifestyle and unhealthy eating habits.
- Growing geriatric population with high risk of CVDs.
- Technological advancements in embolic protection devices that offer enhanced safety and efficacy profiles.
- Rising demand for minimally invasive procedures as they are associated with lesser surgical risks and shorter hospital stays.
- increasing healthcare expenditure by governments and private players to support the growth of the medical device industry
Scope Of The Report
Report Attributes
Report Details
Report Title
Embolic Protection Devices Market Research Report
By Type
Distal Filter Devices, Distal Occlusion Devices, Proximal Occlusion Devices
By Application
Cardiovascular Diseases, Neurovascular Diseases, Peripheral Diseases
By Companies
Medtronic , Abbott Laboratories , Boston Scientific , Cordis (A Cardinal Health Company) , Contego Medical , W.L.Gore & Associates , Silk Road Medical , Claret Medical , Allium Medical Solutions , Angioslide
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
235
Number of Tables & Figures
165
Customization Available
Yes, the report can be customized as per your need.
Global Embolic Protection Devices Market Report Segments:
The global Embolic Protection Devices market is segmented on the basis of:
Types
Distal Filter Devices, Distal Occlusion Devices, Proximal Occlusion Devices
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cardiovascular Diseases, Neurovascular Diseases, Peripheral Diseases
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- MedtronicÂ
- Abbott LaboratoriesÂ
- Boston ScientificÂ
- Cordis (A Cardinal Health Company)Â
- Contego MedicalÂ
- W.L.Gore & AssociatesÂ
- Silk Road MedicalÂ
- Claret MedicalÂ
- Allium Medical SolutionsÂ
- Angioslide
Highlights of The Embolic Protection Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Distal Filter Devices
- Distal Occlusion Devices
- Proximal Occlusion Devices
- By Application:
- Cardiovascular Diseases
- Neurovascular Diseases
- Peripheral Diseases
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Embolic Protection Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Embolic protection devices (EPDs) are medical devices that help to prevent blood clots from forming in the veins and arteries. They work by trapping small pieces of debris, such as dust or hair, that can become embedded in the bloodstream and cause a clot. When these clots form, they can block blood flow and lead to serious health problems. EPsDs are usually placed on the legs or arms during surgery or childbirth to help prevent them from becoming lodged in vital organs.
Some of the key players operating in the embolic protection devices market are Medtronic‚Â , Abbott Laboratories‚Â , Boston Scientific‚Â , Cordis (A Cardinal Health Company)‚Â , Contego Medical‚Â , W.L.Gore & Associates‚Â , Silk Road Medical‚Â , Claret Medical‚Â , Allium Medical Solutions‚Â , Angioslide.
The embolic protection devices market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Embolic Protection Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Embolic Protection Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Embolic Protection Devices Market - Supply Chain
4.5. Global Embolic Protection Devices Market Forecast
4.5.1. Embolic Protection Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Embolic Protection Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Embolic Protection Devices Market Absolute $ Opportunity
5. Global Embolic Protection Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Embolic Protection Devices Market Size and Volume Forecast by Type
5.3.1. Distal Filter Devices
5.3.2. Distal Occlusion Devices
5.3.3. Proximal Occlusion Devices
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Embolic Protection Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Embolic Protection Devices Market Size and Volume Forecast by Application
6.3.1. Cardiovascular Diseases
6.3.2. Neurovascular Diseases
6.3.3. Peripheral Diseases
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Embolic Protection Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Embolic Protection Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Embolic Protection Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Embolic Protection Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Embolic Protection Devices Demand Share Forecast, 2019-2029
9. North America Embolic Protection Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Embolic Protection Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Embolic Protection Devices Market Size and Volume Forecast by Application
9.4.1. Cardiovascular Diseases
9.4.2. Neurovascular Diseases
9.4.3. Peripheral Diseases
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Embolic Protection Devices Market Size and Volume Forecast by Type
9.7.1. Distal Filter Devices
9.7.2. Distal Occlusion Devices
9.7.3. Proximal Occlusion Devices
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Embolic Protection Devices Demand Share Forecast, 2019-2029
10. Latin America Embolic Protection Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Embolic Protection Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Embolic Protection Devices Market Size and Volume Forecast by Application
10.4.1. Cardiovascular Diseases
10.4.2. Neurovascular Diseases
10.4.3. Peripheral Diseases
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Embolic Protection Devices Market Size and Volume Forecast by Type
10.7.1. Distal Filter Devices
10.7.2. Distal Occlusion Devices
10.7.3. Proximal Occlusion Devices
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Embolic Protection Devices Demand Share Forecast, 2019-2029
11. Europe Embolic Protection Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Embolic Protection Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Embolic Protection Devices Market Size and Volume Forecast by Application
11.4.1. Cardiovascular Diseases
11.4.2. Neurovascular Diseases
11.4.3. Peripheral Diseases
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Embolic Protection Devices Market Size and Volume Forecast by Type
11.7.1. Distal Filter Devices
11.7.2. Distal Occlusion Devices
11.7.3. Proximal Occlusion Devices
1.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Embolic Protection Devices Demand Share, 2019-2029
12. Asia Pacific Embolic Protection Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Embolic Protection Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Embolic Protection Devices Market Size and Volume Forecast by Application
12.4.1. Cardiovascular Diseases
12.4.2. Neurovascular Diseases
12.4.3. Peripheral Diseases
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Embolic Protection Devices Market Size and Volume Forecast by Type
12.7.1. Distal Filter Devices
12.7.2. Distal Occlusion Devices
12.7.3. Proximal Occlusion Devices
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Embolic Protection Devices Demand Share, 2019-2029
13. Middle East & Africa Embolic Protection Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Embolic Protection Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Embolic Protection Devices Market Size and Volume Forecast by Application
13.4.1. Cardiovascular Diseases
13.4.2. Neurovascular Diseases
13.4.3. Peripheral Diseases
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Embolic Protection Devices Market Size and Volume Forecast by Type
13.7.1. Distal Filter Devices
13.7.2. Distal Occlusion Devices
13.7.3. Proximal Occlusion Devices
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Embolic Protection Devices Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Embolic Protection Devices Market: Market Share Analysis
14.2. Embolic Protection Devices Distributors and Customers
14.3. Embolic Protection Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Medtronic
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Abbott Laboratories
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Boston Scientific
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Cordis (A Cardinal Health Company)
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Contego Medical
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. W.L.Gore & Associates
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Silk Road Medical
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Claret Medical
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Allium Medical Solutions
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Angioslide
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
